Recursion Pharmaceuticals
ENTRABBNVIDIA partnership + Exscientia merger. Industrialized drug-discovery AI.
recursion.comSalt Lake City, USAFounded 2013750+ employeesPublic · NASDAQ:RXRXBiotech AI · Drug Discovery
Hiring Now
View all 220 roles220 open roles at Recursion Pharmaceuticals
Verified live postings · updated FEB 12, 2026
Get notified when Recursion Pharmaceuticals posts a new role
Free · email when published · no weekly noise
ENTRA Talent Index
Hiring quality verdict.
56/ 100
ENTRABB
Recursion's NVIDIA partnership plus the Exscientia merger anchors industrialized drug-discovery AI at production scale. 220+ AI-tagged roles concentrated in Salt Lake City and Toronto. The thesis is map-the-cell — large-scale phenomic data plus deep-learning models.
Hiring Velocity60
Compensation72
Retention66
Mission Alignment72
Methodology · 5 dimensions equally weightedData as of FEB 12, 2026
Hiring Intelligence
Recursion Pharmaceuticals by the numbers.
Open roles
220
Verified live postings
Hiring velocity · YoY
+48%
Net-new AI hires (12-month)
Funding stage
Public · NASDAQ:RXRX
Biotech AI · Drug Discovery
Salary Intelligence
Verified salary ranges.
Total comp · USD · annual
Senior ML Engineer
$220Kto$380K
Computational Biologist
$180Kto$310K
Leadership
Who runs talent at Recursion Pharmaceuticals.
Chris Gibson
Co-founder & CEO
Latest Coverage
Recursion Pharmaceuticals in ENTRA Intelligence.
Compare with peers
All companiesRecursion Pharmaceuticals vs. peers.
More coverage
Browse all companies in our editorial coverage.